Physician profile
Jeffrey Stagg
NPI 1114485190
$2,220.54
in general payments reported to CMS, 2019-2025
17 companies · $514 in 2025
The $514 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $428 · 2022: $365 · 2023: $579 · 2024: $334 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,427.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $696.80 | 2022-2024 | Spaceoar Vue System - 10ml, Ams 700 Cxr Rte Kit, Ams 700 |
| Coloplast Corp | $358.82 | 2021-2023 | Titan |
| Janssen Biotech, INC. | $308.16 | 2024-2025 | Erleada, Akeega, Balversa |
| Axonics, INC. | $204.01 | 2021-2022 | |
| Procept Biorobotics Corporation | $192.48 | 2022-2025 | |
| Teleflex LLC | $124.45 | 2021 | |
| Janssen Scientific Affairs, LLC | $57.17 | 2025 | Erleada |
| Ferring Pharmaceuticals INC. | $46.76 | 2025 | Adstiladrin |
| Tolmar, INC. | $34.91 | 2025 | Jatenzo, Rubraca, Eligard |
| Caris Mpi, INC. | $33.08 | 2025 | Mi Cancer Seek |
| Urogen Pharma, INC. | $31.54 | 2025 | |
| Sumitomo Pharma America, INC. | $25.87 | 2025 | Orgovyx |
| Abbvie INC. | $25.70 | 2024 | |
| Innovation Technologies INC | $25.03 | 2021 | |
| 180 Medical, INC. | $21.72 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.98 | 2024 | |
| Clarus Therapeutics INC. | $15.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Stagg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.